Sanofi ADR (SNY)
NASDAQ
Closed
Oct 9, 2026
Day's Range
39.9252 wk Range
39.18Overview - SNY - Sanofi ADR
Key Statistics
Valuation
Enterprise Value
127.48B
P/E (Trailing)
‪21.01‬
P/E (Forward)
‪7.39‬
PEG Ratio
‪7.39‬
Price / Sales (TTM)
‪1.95‬
Price / Book
‪1.21‬
EV / EBITDA
‪8.36‬
Profitability
Gross Margin
‪75.47%‬
Profit Margin
‪8.09%‬
Operating Margin
‪21.03%‬
Return on Assets
‪5.09%‬
Return on Equity
‪5.70%‬
Ownership
Shares Outstanding
1.21B
Float
2.16B
Short % of Shares Outstanding
‪0.44%‬
Held by Insiders
‪0.0010%‬
Held by Institutions
‪8.01%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪43.39‬
200-Day Avg
‪45.05‬
Dividends
Payout Ratio
‪127.51%‬
Frequency
Annual
Analyst Consensus
11 analysts
Average price target
‪$ 53.72‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SNY - Sanofi ADR
Peers - SNY - Sanofi ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- SNYNASDAQSanofi ADR95.65BMarket Cap-24.52%52-week change21.01P/E (Trailing)‪8.09%‬Profit Margin
- AZNNASDAQAstraZeneca PLC243.33BMarket Cap-8.97%52-week change23.59P/E (Trailing)‪17.02%‬Profit Margin
- AMGNNASDAQAmgen Inc.217.89BMarket Cap+27.02%52-week change25.05P/E (Trailing)‪22.95%‬Profit Margin
- GILDNASDAQGilead Sciences, Inc.179.47BMarket Cap+21.53%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.36.00BMarket Cap-39.80%52-week change15.21P/E (Trailing)‪30.24%‬Profit Margin
- BIIBNASDAQBiogen Inc.32.48BMarket Cap+29.94%52-week change39.06P/E (Trailing)‪8.32%‬Profit Margin
- GRFSNASDAQGrifols S.A. ADR4.97BMarket Cap-31.46%52-week change9.75P/E (Trailing)‪6.09%‬Profit Margin
Profile Summary - SNY - Sanofi ADR
About
Sanofi ADR is an American Depositary Receipt representing shares of Sanofi, a global healthcare company focused on pharmaceuticals and vaccines. Through its ADR program, U.S. investors can access the company’s ordinary shares in a form that is traded in the United States, while the underlying business remains centered…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
